Mexico - Delayed Quote MXN

Médica Sur, S.A.B. de C.V. (MEDICAB.MX)

40.60 0.00 (0.00%)
At close: April 26 at 11:30 AM CST
Key Events
Loading Chart for MEDICAB.MX
DELL
  • Previous Close 40.60
  • Open 40.60
  • Bid 40.50 x 137500
  • Ask 40.80 x 5500
  • Day's Range 40.60 - 40.80
  • 52 Week Range 37.00 - 52.02
  • Volume 3,862
  • Avg. Volume 3,721
  • Market Cap (intraday) 4.382B
  • Beta (5Y Monthly) 0.58
  • PE Ratio (TTM) 8.32
  • EPS (TTM) 4.88
  • Earnings Date --
  • Forward Dividend & Yield 33.36 (82.17%)
  • Ex-Dividend Date May 30, 2023
  • 1y Target Est 68.00

Médica Sur, S.A.B. de C.V. operates as a healthcare hospital in Mexico. It offers angiology, vascular, and endovascular surgery; bariatric surgery; cancer; cardiology; checkup and preventive medicine; children; dental; emergency; endocrinology; general; geriatric; gynecology and obstetrics; specialized; imaging unit; MRI unit; neonatology; orthopedic and traumatology; urology; transplant; spine microsurgery; robotic; plastic; and outpatient surgeries. The company was incorporated in 1966 and is based in Mexico City, Mexico. Médica Sur, S.A.B. de C.V. is a subsidiary of Neuco, SAPI de CV.

www.medicasur.com.mx

2,004

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: MEDICAB.MX

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

MEDICAB.MX
0.07%
S&P/BMV IPC
0.78%

1-Year Return

MEDICAB.MX
2.97%
S&P/BMV IPC
6.37%

3-Year Return

MEDICAB.MX
174.05%
S&P/BMV IPC
17.81%

5-Year Return

MEDICAB.MX
243.91%
S&P/BMV IPC
28.44%

Compare To: MEDICAB.MX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MEDICAB.MX

Valuation Measures

Annual
As of 4/28/2024
  • Market Cap

    4.38B

  • Enterprise Value

    4.74B

  • Trailing P/E

    8.32

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.10

  • Price/Book (mrq)

    2.19

  • Enterprise Value/Revenue

    1.18

  • Enterprise Value/EBITDA

    4.98

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    15.38%

  • Return on Assets (ttm)

    10.45%

  • Return on Equity (ttm)

    24.47%

  • Revenue (ttm)

    4.13B

  • Net Income Avi to Common (ttm)

    557.89M

  • Diluted EPS (ttm)

    4.88

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    704.74M

  • Total Debt/Equity (mrq)

    51.48%

  • Levered Free Cash Flow (ttm)

    302.46M

Research Analysis: MEDICAB.MX

Analyst Price Targets

68.00
68.00 Average
40.60 Current
68.00 High
 

Fair Value

 

Company Insights: MEDICAB.MX

People Also Watch